Sign Up Today and Learn More About BioAegis Therapeutics Stock
Invest in or calculate the value of your shares in BioAegis Therapeutics or other pre-IPO companies through EquityZen's platform.
BioAegis Therapeutics Stock (BITE)
BioAegis Therapeutics develops a portfolio of biomarker-directed treatments across a range of indications.
About BioAegis Therapeutics Stock
Founded
2011
Headquarters
Morristown, NJ, US
Industries
Science and Engineering, Health Care, Biotechnology
BioAegis Therapeutics Press Mentions
Stay in the know about the latest news on BioAegis Therapeutics
BioAegis Therapeutics to Present at Upcoming MedInvest Biotech & Pharma Investor Conference in NYC
globenewswire • Sep 13, 2024
BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients ...
finance • May 24, 2024
Tony McMullen on LinkedIn: IEEE PES T&D Expo Join us for an Actalent Happy Hour Tuesday, May 7th -…
linkedin • May 23, 2024
Compositions and synergistic methods for treating infections
patents • Apr 15, 2024
Compositions comprising gelsolin for treating frailty
patents • Apr 15, 2024
BioAegis Therapeutics Management
Leadership team at BioAegis Therapeutics
Corporate Development and Communications
Steven Cordovano
Chief Executive Officer
Susan Levinson
Join now and verify your accreditation status to gain access to:
- BioAegis Therapeutics current valuation
- BioAegis Therapeutics stock price
- Available deals in BioAegis Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in BioAegis Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like BioAegis Therapeutics through EquityZen funds. These investments are made available by existing BioAegis Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell BioAegis Therapeutics stock?
Shareholders can sell their BioAegis Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
